Pilot Study of Sodium-Glucose Cotransporter 2 Inhibitor Empagliflozin Shows Reduced Intrarenal Complement Activation in Patients With Diabetes and CKD

Mia Jensen*, Steffen F. Nielsen, Steffen Thiel, Søren Hansen, Yaseelan Palarasah, Per Svenningsen, Jesper N. Bech, Frank H. Mose, Boye Lagerbon Jensen

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

1 Downloads (Pure)
Original languageEnglish
JournalKidney International Reports
Volume10
Issue number2
Pages (from-to)591-595
ISSN2468-0249
DOIs
Publication statusPublished - Feb 2025

Keywords

  • kidney injury
  • lectin cascade
  • type 2 diabetes mellitus

Cite this